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Anthrax toxin binds to a plasma membrane receptor and
after endocytosis exerts its deadly effects on the cell. Until
now, however, the mechanism of initial toxin uptake was
unknown. In this issue, Abrami et al. (2003) demonstrate
that toxin oligomerization clusters the anthrax receptor
into lipid rafts and this complex is internalized via the
clathrin-dependent pathway.
 
Anthrax caused by 
 
Bacillus anthracis
 
 is one of the oldest diseases
of cattle and humans known to mankind. Unfortunately,
recent events have revived public interest in this menace.
Much effort in the past was devoted to understanding the
etiology of the disease and to identifying virulence factors
(i.e., toxins) that caused the death of target cells. Surprisingly,
until recently, little was known about the entry of anthrax
toxin into cells. In this issue, a paper by the group of Gisou
van der Goot (Abrami et al., 2003) provides evidence for a
direct link between anthrax toxin entry and lipid rafts on the
surface of the cell. This work is significant for both its medical
importance and as a demonstration of how lipid rafts function
in biological processes.
 
The anthrax toxin is a tripartite virulent factor produced
 
by 
 
Bacillus anthracis
 
. Two subunits, edema factor (EF;* a
calmodulin-dependent cyclase) and lethal factor (LF; a
metalloprotease that targets MAPK kinases) are responsible
for the toxin’s virulence by enzymatically modifying sub-
strates in the cytosol. However, they cannot exert their effects
without a third 83-kD protein called protective antigen
 
(PA83) that facilitates their entry into the cell. Recently,
an integral membrane protein receptor for PA83, termed
 
anthrax toxin receptor (ATR), was identified (Bradley et
al., 2001). PA83 bound to the surface receptor is processed
by furin family proteases to a 63-kD protein (PA63) that
oligomerizes to form a heptameric ring (Petosa et al.,
1997). Only after this step can LF and/or EF be bound
(Cunningham et al., 2002). The receptor is then internalized
into endosomes where at low pH a channel forms, allowing
the entry of LF and EF into the cytoplasm of the cell
(Mourez et al., 2002). Abrami et al. (2003) now provide an
exciting molecular mechanism for the initial steps of anthrax
toxin internalization involving receptor interaction with
lipid rafts.
Lipid rafts are postulated to be cholesterol- and glycosphin-
golipid-enriched microdomains of the cell plasma membrane
that differ in their physical properties from the rest of the
membrane (Simons and Ikonen, 1997). Some membrane
proteins associate specifically with these microdomains,
whereas others avoid them. Rafts are envisaged as concen-
trating devices in many signaling processes and intracellular
transport pathways. It must be noted that so far there are no
biochemical methods for isolation of pure rafts. However,
they are operationally defined as entities resistant to solubili-
zation by cold nonionic detergents and found in light (buoyant)
fractions upon centrifugation on an equilibrium sucrose
gradient (Simons and Toomre, 2000). Abrami et al. (2003)
use this operational definition whenever referring to rafts.
One of the major findings of the paper is that ATR bound
to heptameric PA63, but not monomeric PA83, is tightly
associated with lipid rafts. This interaction can be abolished
by the depletion or reduction of the major raft constituents
cholesterol and sphingomyelin. The processing of PA83 to
PA63 and subsequent heptamerization appears to cluster the
ATR into rafts and have important consequences. Normally,
endocytosis of the ATR is slow, allowing time for PA83 to
be cleaved by furin proteases, only a small fraction of which
are present on the cell surface. PA63, but not PA83, is com-
petent to bind the virulence factors EF and LF, and the
complex is now rapidly internalized. As the authors state,
this makes ATR an ideal receptor for the toxin.
To enter cells, toxins or viruses usually utilize an existing
transport pathway. The anthrax toxin does not seem to be
an exception and uses for its “egotistic” purposes the intrinsic
properties of rafts and raft-associated proteins. Experiments
described by Abrami et al. (2003) reveal two new properties of
raft-dependent processes. First, oligomerization of a protein
may facilitate its association with rafts, and second, this asso-
ciation may accelerate its endocytosis. It is not clear, though,
why ATR bound to PA63 should be tightly associated with
rafts. Does the heptamerization of PA63 drive this event?
The authors address this question by incubating cells with
antibodies against PA83 to cluster the ATR in the absence of
PA63. Remarkably, cross-linking with antibodies led to the
association of PA83-bound ATR with rafts, indicating that
oligomerization itself was sufficient to relocalize ATR. This
relocalization was cholesterol dependent. As important as
these data are, they raise even more questions. Is the oligo-
 
Address correspondence to Teymuras Kurzchalia, MPI for Cell Biology
and Genetics, Pfotenhauerstr. 108, D-01307 Dresden, Germany. Tel.: 49-
351-210-2567. Fax: 49-351-210-2000. E-mail: kurzchalia@mpi-cbg.de
*Abbreviations used in this paper: ATR, anthrax toxin receptor; EF,
edema factor; LF, lethal factor.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
296 The Journal of Cell Biology 
 
|
 
 
 
Volume 160, Number 3, 2003
 
merization of a protein a general prerequisite for its localiza-
tion to rafts, or is it a specific property of ATR? Why do other
proteins (e.g., the LDL receptor or the transferrin receptor
[Harder et al., 1998]) not enter rafts upon clustering? It will
definitely be important to determine if oligomerization can
be separated from the raft association. Indeed, the entry of
the anthrax toxin into cells provides a way to study this.
The authors also take a first step toward understanding
why raft-associated heptameric PA63 is internalized much
more efficiently than PA83 by identifying the pathway re-
sponsible for endocytosis. One possible mechanism for in-
ternalizing the heptameric PA63-bound ATR was via caveo-
lae. These are small invaginations on the surface of many
cells and are considered as specific forms of rafts (Kurzchalia
and Parton, 1999). Recent studies have demonstrated that
simian virus SV40 uses caveolae as an endocytotic vehicle
(Pelkmans and Helenius, 2002). Surprisingly, although the
regulation of endocytosis of anthrax toxin relies on rafts, in-
ternalization of the receptor does not occur by caveolae. In
another series of experiments, they demonstrated that hep-
tameric PA63 utilizes the classical clathrin-dependent en-
docytic pathway. In this respect, the endocytosis of ATR
resembles that of the B cell receptor, which undergoes
ligand-dependent clustering, raft association, and then is in-
ternalized via a clathrin-dependent mechanism (Cheng et al.,
1999). A fundamental task for the future will be to clarify how
internalization of rafts by the clathrin-dependent pathway is
regulated. In the case of anthrax toxin, understanding this
process could have important medical implications.
Abrami et al. (2003) clearly demonstrate the physiological
relevance of raft integrity to toxin effects. In cells incubated
with 
 
 
 
-methyl cyclodextrin, a reagent that removes choles-
terol from the plasma membrane and thus disaggregates
rafts, the PA63/LF complex was less efficiently internalized
relative to control cells. As a consequence, LF no longer en-
tered the cytoplasm and cleaved the MAPK kinase, MEK1,
thus abolishing its toxic effects. Without being overtly opti-
mistic, one can imagine that in the future rafts may be thera-
 
peutic targets for drugs against anthrax or other raft-based
diseases. The problem to be solved, however, will be to de-
sign drugs that disintegrate only a specific subset of rafts.
Randomly extracting cholesterol from the cells of an organ-
ism or tissue will not be an acceptable cure for anthrax. In
summary, the paper by van der Goot’s group (Abrami et al.,
2003) exposes a new function for lipid rafts in cells and pro-
vides another example of how a toxin can usurp a physiolog-
ically relevant process for its own purposes.
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